Wednesday, October 15, 2014 6:01:25 PM
"The federal government is in the middle in this case, agreeing with Teva that the Federal Circuit should show more respect for a district trial judge’s factual conclusions, but agreeing with the generics that, in the end, the courts probably are going to be led to the conclusion that Teva is not entitled to a patent on its Copaxone medicine for multiple sclerosis patients."
Note too that...
"The high court’s interest in patent cases has been linked to divisions among judges on the U.S. Court of Appeals for the Federal Circuit, which handles all patent appeals.
The high court reversed the appeals court in five of the six patent cases it heard last term.
The Teva case could have broad ramifications in the patent world because it addresses how much leeway the appeals court has to second-guess district court judges."
Patents are getting a raw deal all around when compared to the copyright on music. Life of the artist + 70 years.
But, I say, wouldn't putting those notes and beats and words in that order be common sense?
Clap along if you feel like happiness is the truth ...
Isn't "Happy Birthday" OBVIOUS? (copyright doesn't expire until at least 2030)
When you insert the birthday person's name in the song isn't that like the generic equivalent of a 4 billion dollar drug?
Ugh!!!
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM